MedTrace Logo

Dietetic Efficacy of Mare's Milk for Patients With Chronic Inflammatory Bowel Diseases

NCT00940576 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2015-05-25

Study results available
· View outcomes & findings →

Summary

Mare's milk consumption could improve the well-being in patients with Crohn's disease and ulcerative colitis, respectively.

Conditions

Interventions

DIETARY_SUPPLEMENT

mare´s milk

oral intake of 250 ml mare's milk first, then placebo drink daily during 8 weeks of each (cross over design)

OTHER

placebo drink

oral intake of 250 ml placebo drink first, then mare's milk daily during 8 weeks of each (cross over design)

Sponsors & Collaborators

  • German Federal Ministry of Education and Research

    collaborator OTHER_GOV

  • University of Jena

    lead OTHER

Principal Investigators

  • Gerhard Jahreis, Prof. Dr. · Professor in Ordinary

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
10 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-07-31
Primary Completion
2001-02-28
Completion
2001-02-28

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00940576 on ClinicalTrials.gov